Redox (RDX) H2 2025 earnings summary

Executive summary

• Achieved 9.4% revenue growth to $1.244 billion for FY25, driven by strong volume increases and three completed acquisitions (Oleum, Auschem, Molekulis), despite subdued demand and a challenging macroeconomic environment.

• Gross profit increased 1% to $269 million, with gross margin at 21.6%, within the historical 20%-22% range.

• Net cash position was $124 million, maintaining zero net debt and supporting future investments.

• Sales team expanded by 7.2% to 194 members to support organic growth and new customer wins.

• Dividend payout ratio was 85% of NPAT, with a total dividend of $0.125 per share.

Financial highlights

• Sales revenue rose 9.4% year-over-year to $1.244 billion; gross profit up 1% to $269 million.

• Gross profit margin was 21.6%, down 1.8 percentage points year-over-year.

• Underlying NPATFX declined $15 million to $80 million as margins normalized.

• Free cash flow conversion dropped to 40.7% as inventories and receivables grew.

• Net working capital increased to $407 million (32.7% of sales), above the historical range.

Outlook and guidance

• Management expects conditions to improve in FY26, with July 2025 sales and volumes up 13% year-over-year, indicating a strong start.

• Focus remains on organic growth, product portfolio expansion, and strategic M&A, especially in North America.

• Long-term sales growth targeted at 10% and profit growth at 11%, with operating leverage expected as cost pressures normalize.

• Macroeconomic and geopolitical headwinds are expected to persist, but financial strength and flexibility position the company for future growth.